StocksDeepDive
Snapshot · Russell 3000 · generated 2026-10-17 22:04 UTC

PTCT — PTC Therapeutics, Inc.

UNDERVALUED (MOS +66.1%) · Quality 52/100

Price
59.24
Intrinsic value
174.89
Margin of safety
+66.1%
Implied growth (reverse DCF)
-1.8%
model assumes +15.8%
Value Score
44.5
Quality
52
Psychology
24.5
Discovery
15.5
price/volume attention only
Moat score
81.2
erosion: none

Value Score: top 13% of Russell 3000 · Quality: bottom 43%

Open the interactive Deep Dive for PTCT →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/PTCT - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is PTCT undervalued?

As of 2026-10-17, PTCT trades at 59.24 against a computed intrinsic value of 174.89 (+66.1% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is PTC Therapeutics, Inc.'s Value Score?

PTC Therapeutics, Inc.'s Value Score is 44.5 as of 2026-10-17 - it combines value, quality, crowd psychology and market attention into one number.